Pfizer Hit With Class Action Lawsuits Alleging Generic Celebrex Delay

Generic Line
Pfizer is facing at least three class action lawsuits alleging that the company went to extraordinary, fraudulent lengths to maintain exclusivity over its multibillion dollar arthritis pain drug Celebrex and keep generic competitors off the market.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00